justice lawyers
FREE case evaluation:
email us or call
1-800-513-1609
   
drug recall news
Nursing home abuse news
stock fraud news
Leukemia health news

Leukemia
One in 79 men and women in America will be diagnosed with leukemia during his or her lifetime, according to a National Cancer Institute SEER report. Though the survival rate for patients undergoing leukemia treatments has increased, leukemia continues to kill over 20,000 Americans each year. Learn more about leukemia and new treatments by clicking here.
Studies continue to show that alternative medicine can help recovery time and mental wellbeing of leukemia patients. To learn the differences between alternative and Western approaches to leukemia treatments or to find tips for seeking out an alternative healer, read our recent newsletter on Alternative Medicine & Leukemia Treatment.

Bad Blood Caused by Industry Abuses
Benzene as a known cause of leukemia had documented since 1948 when the American Petroleum Institute officially reported a link between this solvent used in many of its industries and cases of leukemia in its workers. Their findings concluded that there is no safe level of benzene exposure. Benzene for over a decade has carries the EPA’s “known carcinogen” designation. Yet, despite these facts, industries from tire manufacturers to microprocessor factories continue to use benzene at unsafe levels, making it one of the top 20 chemicals produced in volume in the United States. Click to read more about Leukemia and the Workplace.

If you believe industry has caused your leukemia, contact the Consumer Justice Group immediately. Limits exist on the time you have to act. Let us begin work for you today.


MORE STORIES IN THIS ISSUE

- The Future of Leukemia Treatments is Here…
- Leukemia Finds Its Way into the Workplace...
- Alternative Medicine & Options…
- Qualifying for Clinical Trials…
- Benzene, Killer of American Working Class…

VIEW ALL OF OUR NEWSLETTERS!

- Stock Fraud News
- Drug Recall News
- Workers' Compensation News
- Nursing Home Abuse & Neglect News
- Leukemia Health News

 

 

 

 

 

FDA

Statement by Dr. Lester M. Crawford, Acting FDA Commissioner, on Outside Activities of FDA Employees

Like its sister agencies in the U.S. Department of Health and Human Services, the Food and Drug Administration (FDA) is a public health agency. But FDA is unique in the Department because it is primarily a regulatory agency.

As a result, for more than three decades FDA has had an aggressive disclosure and review process that is designed to ensure that its employees do not have any conflict of interest involving companies and entities that FDA "significantly regulates."

To maintain the public trust in its public health work, FDA has placed reasonable restrictions on the financial and employment ties between FDA employees and the entities it regulates.

Since 1970, review of FDA employees' requests to participate in outside activities has occurred within the FDA centers, at levels below that of the Center Director. I believe that this authority should be delegated to a higher level, so on May 6th I issued an interim policy on the approval of outside activities. Under this policy, FDA Center Directors must review and, if an activity is allowed, approve all outside activity requests.

In light of recent questions about possible conflicts of interest involving HHS agencies, I have also directed a comprehensive review of all current outside activity requests from all FDA employees. Once that review has been completed, FDA will issue a final policy on the review and approval of outside activities.

FDA's commitment to the highest ethical standards in its dealings with regulated entities remains constant. I am confident that the current review of FDA employees' outside activities will show that the nation is well served by the dedication of FDA's expert scientists and physicians and their demonstrated ability to conduct the public business fairly and impartially.

Return to FDA Recall News

This page is an advertisement of the Consumer Justice Group, LLC. The opinions expressed herein are those of the Consumer Justice Group. The Group is a Washington, DC law firm. This website is not a solicitation for business in any other jurisdiction. The laws of the District of Columbia apply to this website. The information contained herein is not legal advice. All trademarks and copyrights are those of their respective owners.